Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
China · Delayed Price · Currency is CNY 13.69
-0.55 (-3.86%)
Apr 9, 2026, 3:04 PM CST
SHE:002923 Revenue
Zhuhai Rundu Pharmaceutical had revenue of 336.33M CNY in the quarter ending September 30, 2025, with 20.20% growth. This brings the company's revenue in the last twelve months to 1.19B, down -2.76% year-over-year. In the year 2024, Zhuhai Rundu Pharmaceutical had annual revenue of 1.18B, down -8.48%.
Revenue (ttm)
1.19B
Revenue Growth
-2.76%
P/S Ratio
4.01
Revenue / Employee
599.38K
Employees
1,985
Market Cap
4.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.18B | -109.52M | -8.48% |
| Dec 31, 2023 | 1.29B | -80.35M | -5.86% |
| Jan 1, 2023 | 1.37B | 182.31M | 15.32% |
| Jan 1, 2022 | 1.19B | -62.70M | -5.01% |
| Dec 31, 2020 | 1.25B | -107.28M | -7.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.20B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Fuan Pharmaceutical (Group) | 1.71B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Bide Pharmatech | 1.32B |
| Tibet Weixinkang Medicine | 1.17B |
| Newland Pharmaceutical | 672.38M |